PTC Therapeutics Corp (PTCT): Rasio rega marang pendapatan

Tandha merek PTC Therapeutics Corp (PTCT)

The price-to-sales multiple reflects the dynamics of PTC Therapeutics, Inc. (PTCT), which develops therapies for rare brain pathologies relying on strict temperature-controlled supply chains. Stable demand for orphan drugs drives growth through new approvals. The value of 4.60 represents the latest metric reading, while geopolitical disruptions could hinder the conduct of global trials and patient access to innovations.

PTCT Multiplikator P/S PTC Therapeutics, Inc. (04.07.2022 - 14.11.2026)

Rincian metrik lan analitis perusahaan PTC Therapeutics Corp (PTCT)

- kuotasi saiki lan rata-rata prakiraan nilai:
Rega bursa ptcbio.com|PTCT - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar PTC Therapeutics Corp|PTCT - Nilai Total Perusahaan
- statistik nilai buku emiten:
Nilai Aset Bersih saben Saham PTC Therapeutics|PTCT - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas ptcbio.com|PTCT - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Modal PTC Therapeutics, Inc.|PTCT - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas PTC Bio|PTCT - Gunggung utang perusahaan|Utang marang modal buku PTC Therapeutics Corp|PTCT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan PTC Therapeutics|Rasio jangkoan perantara ptcbio.com
- data bathi lan kelipatan valuasi:
PTCT - Penghasilan resik|Bathi resik mangsa ngarep PTC Therapeutics, Inc.|PTCT - Pangali P/E|Pangali mangsa ngarep rega marang bathi PTC Therapeutics Inc|PTCT - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PTC Therapeutics Corp|PTCT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku PTC Therapeutics|PTCT - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan ptcbio.com|PTCT - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PTC Therapeutics, Inc.
- rincian pendapatan lan dodolan emiten:
PTCT - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan ptcbio.com|PTCT - Kapitalisasi marang pendapatan|Multiplikator Forward P/S PTC Therapeutics Corp
Ringkesan analitik perusahaan:ptcbio.com
Produk seri PTC Therapeutics Inc

The monopoly position of PTC Therapeutics, Inc. (PTCT) in the orphan drug segment, shielded from competition by high R&D costs, makes the company's revenue a stable foundation of value. Monitoring the company's P/S ratio allows for the correlation of market capitalization with this cash flow, determining whether an investor is overpaying for the uniqueness of the assets or if conditions have been created for a price correction.

Perusahaan pesaing

JAZZ - Rega marang dodolan|Rasio rega marang pendapatan Cytokinetics, Incorporated CYTK|Scholar Rock, Inc. - Rasio rega marang pendapatan|CNTA - Rasio rega marang pendapatan|Rega marang dodolan Dyne Corp|EWTX: Multiplikator P/S|Multiplikator rega marang pendapatan rapportrx.com RAPP|Kapitalisasi marang pendapatan ALMS|Rega marang dodolan Zevra Therapeutics Inc ZVRA|Rasio rega marang pendapatan Contineum Pharma (CTNM)|LRMR: Rasio rega marang dodolan|Capricor Therapeutics, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TRDA (entradatx.com)|Channel Therapeutics Corp - Multiplikator P/S|MediciNova, Inc. (MNOV) - Kapitalisasi marang pendapatan|SER (Serina) - Kapitalisasi marang pendapatan|BioXcel Therapeutics Corp - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan PMN|APUS (Apimeds) - Kapitalisasi marang volume dodolan|Multiplikator P/S AEON|NLSP (nlspharma.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S BNOX (Bionomics)|fsdpharma.com (HUGE) - Rega marang dodolan|RETA - Rasio rega marang pendapatan